SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Courtesy of AbbVie

111

AbbVie

ABBV

The pharmaceutical company makes drugs to treat HIV, psoriasis, rheumatiod arthritis, low testosterone, thyroid problems, and Parkinson’s.

Looking for leads, investment insights, or competitive intelligence?

CEO

Richard A. Gonzalez

CEO Title

Chairman & Chief Executive Officer

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

North Chicago, IL

Years on Fortune 500 List

4

Employees

30,000

Profile provided by S&P Global.
AbbVie is also featured in these fortune lists
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$25,63812.2%
Profits ($M)$5,953.015.7%
Assets ($M)$66,099
Total Stockholder Equity ($M)$4,636
Market Value — as of March 31, 2017 ($M)$103,838
Profit Ratios
Profit as % of Revenues23.2%
Profits as % of Assets9.0%
Profits as % of Stockholder Equity128.4%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)3.63
EPS % Change (from 2015)16.0%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-
Total Return
Total Return to Investors (2016)9.7%
Total Return to Investors (5 year, annualized)-
Total Return to Investors (10 year, annualized)-
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about AbbVie

Could a New Immunotherapy Medical Approach Break the Alzheimer's Drug Curse?

AbbVie and Alector hope to apply immunotherapy to dementia and Alzheimer's.

Read More →
Valeant's New CEO Joe Papa Has a $17 Billion Ultimatum

If he pulls it off, he will make more than all of his peers combined.

Read More →